Wei Y, Chiang W, Sumpter R, Mishra P, Levine B. Prohibitin 2 Is an Inner Mitochondrial Membrane Mitophagy Receptor. Cell. 2017;168:224-238.e10 pubmed publisher

Kucuk I, Tanoglu A, Oncu K, Yilmaz I, Kara M, Beyazit Y, et al. Immunohistochemical activity of Prohibitin-2 and Stomatin-Like Protein-2 in patients with ulcerative colitis. Turk J Gastroenterol. 2016;27:233-8 pubmed publisher

Gu X, Hu Z, Ebrahem Q, Crabb J, Mahfouz R, Radivoyevitch T, et al. Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy. J Biol Chem. 2014;289:14881-95 pubmed publisher

Sun S, Hou H, Ma G, Ma Q, Li N, Zhang L, et al. The interaction between E3 ubiquitin ligase Parkin and mitophagy receptor PHB2 links inner mitochondrial membrane ubiquitination to efficient mitophagy. J Biol Chem. 2022;298:102704 pubmed publisher

Hahn C, Tyka K, Saba J, Lenzen S, Gurgul Convey E. Overexpression of sphingosine-1-phosphate lyase protects insulin-secreting cells against cytokine toxicity. J Biol Chem. 2017;292:20292-20304 pubmed publisher

Cheng J, Gao F, Chen X, Wu J, Xing C, Lv Z, et al. Prohibitin-2 promotes hepatocellular carcinoma malignancy progression in hypoxia based on a label-free quantitative proteomics strategy. Mol Carcinog. 2014;53:820-32 pubmed publisher

Cunningham D, Creese A, Auciello G, Sweet S, Tatar T, Rappoport J, et al. Novel binding partners and differentially regulated phosphorylation sites clarify Eps8 as a multi-functional adaptor. PLoS ONE. 2013;8:e61513 pubmed publisher